160 related articles for article (PubMed ID: 19837632)
21. Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells.
Sapoznikov A; Fischer JA; Zaft T; Krauthgamer R; Dzionek A; Jung S
J Exp Med; 2007 Aug; 204(8):1923-33. PubMed ID: 17646404
[TBL] [Abstract][Full Text] [Related]
22. Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help.
Decker WK; Xing D; Li S; Robinson SN; Yang H; Yao X; Segall H; McMannis JD; Komanduri KV; Champlin RE; Shpall EJ
Vaccine; 2006 Apr; 24(16):3203-16. PubMed ID: 16480795
[TBL] [Abstract][Full Text] [Related]
23. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
[TBL] [Abstract][Full Text] [Related]
24. CRTAM confers late-stage activation of CD8+ T cells to regulate retention within lymph node.
Takeuchi A; Itoh Y; Takumi A; Ishihara C; Arase N; Yokosuka T; Koseki H; Yamasaki S; Takai Y; Miyoshi J; Ogasawara K; Saito T
J Immunol; 2009 Oct; 183(7):4220-8. PubMed ID: 19752223
[TBL] [Abstract][Full Text] [Related]
25. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.
Jenne L; Arrighi JF; Jonuleit H; Saurat JH; Hauser C
Cancer Res; 2000 Aug; 60(16):4446-52. PubMed ID: 10969791
[TBL] [Abstract][Full Text] [Related]
26. Immune response in cervical lymph nodes from patients with primary oral squamous cell carcinoma.
Gonçalves AS; Costa NL; Arantes DA; de Cássia Gonçalves Alencar R; Silva TA; Batista AC
J Oral Pathol Med; 2013 Aug; 42(7):535-40. PubMed ID: 23278174
[TBL] [Abstract][Full Text] [Related]
27. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.
Oizumi S; Strbo N; Pahwa S; Deyev V; Podack ER
J Immunol; 2007 Aug; 179(4):2310-7. PubMed ID: 17675492
[TBL] [Abstract][Full Text] [Related]
28. Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes.
Hickman HD; Takeda K; Skon CN; Murray FR; Hensley SE; Loomis J; Barber GN; Bennink JR; Yewdell JW
Nat Immunol; 2008 Feb; 9(2):155-65. PubMed ID: 18193049
[TBL] [Abstract][Full Text] [Related]
29. Lymphatic dysfunction attenuates tumor immunity through impaired antigen presentation.
Kimura T; Sugaya M; Oka T; Blauvelt A; Okochi H; Sato S
Oncotarget; 2015 Jul; 6(20):18081-93. PubMed ID: 26098776
[TBL] [Abstract][Full Text] [Related]
30. Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells.
Vuylsteke RJ; van Leeuwen PA; Meijer S; Wijnands PG; Statius Muller MG; Busch DH; Scheper RJ; de Gruijl TD
Am J Pathol; 2002 Jul; 161(1):19-26. PubMed ID: 12107085
[TBL] [Abstract][Full Text] [Related]
31. Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells.
Yu P; Spiotto MT; Lee Y; Schreiber H; Fu YX
J Exp Med; 2003 Apr; 197(8):985-95. PubMed ID: 12695490
[TBL] [Abstract][Full Text] [Related]
32. Collateral presentation of antigens as physiological prototype for lymph node metastases.
Manskikh VN; Perelmuter VM
Biochemistry (Mosc); 2013 Mar; 78(3):314-23. PubMed ID: 23586727
[TBL] [Abstract][Full Text] [Related]
33. Incomplete differentiation of antigen-specific CD8 T cells in tumor-draining lymph nodes.
Hargadon KM; Brinkman CC; Sheasley-O'neill SL; Nichols LA; Bullock TN; Engelhard VH
J Immunol; 2006 Nov; 177(9):6081-90. PubMed ID: 17056534
[TBL] [Abstract][Full Text] [Related]
34. Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity.
Noubade R; Majri-Morrison S; Tarbell KV
Front Immunol; 2019; 10():1014. PubMed ID: 31143179
[TBL] [Abstract][Full Text] [Related]
35. Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma.
Roberts EW; Broz ML; Binnewies M; Headley MB; Nelson AE; Wolf DM; Kaisho T; Bogunovic D; Bhardwaj N; Krummel MF
Cancer Cell; 2016 Aug; 30(2):324-336. PubMed ID: 27424807
[TBL] [Abstract][Full Text] [Related]
36. Cross-Priming Dendritic Cells Exacerbate Immunopathology After Ischemic Tissue Damage in the Heart.
Forte E; Perkins B; Sintou A; Kalkat HS; Papanikolaou A; Jenkins C; Alsubaie M; Chowdhury RA; Duffy TM; Skelly DA; Branca J; Bellahcene M; Schneider MD; Harding SE; Furtado MB; Ng FS; Hasham MG; Rosenthal N; Sattler S
Circulation; 2021 Feb; 143(8):821-836. PubMed ID: 33297741
[TBL] [Abstract][Full Text] [Related]
37. Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation Therapy.
Blair TC; Bambina S; Alice AF; Kramer GF; Medler TR; Baird JR; Broz ML; Tormoen GW; Troesch V; Crittenden MR; Gough MJ
J Immunol; 2020 Jun; 204(12):3416-3424. PubMed ID: 32341058
[TBL] [Abstract][Full Text] [Related]
38. Metastasis to sentinel lymph nodes in breast cancer is associated with maturation arrest of dendritic cells and poor co-localization of dendritic cells and CD8+ T cells.
Mansfield AS; Heikkila P; von Smitten K; Vakkila J; Leidenius M
Virchows Arch; 2011 Oct; 459(4):391-8. PubMed ID: 21894561
[TBL] [Abstract][Full Text] [Related]
39. Cancer immunotherapy by dendritic cells.
Melief CJ
Immunity; 2008 Sep; 29(3):372-83. PubMed ID: 18799145
[TBL] [Abstract][Full Text] [Related]
40. Shaping naive and memory CD8+ T cell responses in pathogen infections through antigen presentation.
Belz GT; Wilson NS; Kupresanin F; Mount AM; Smith CM
Adv Exp Med Biol; 2007; 590():31-42. PubMed ID: 17191375
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
